| Management of glioblastoma: State of the art and future directions AC Tan, DM Ashley, GY López, M Malinzak, HS Friedman, M Khasraw CA: a cancer journal for clinicians 70 (4), 299-312, 2020 | 1700 | 2020 |
| Targeted therapies for lung cancer patients with oncogenic driver molecular alterations AC Tan, DSW Tan Journal of Clinical Oncology 40 (6), 611-625, 2022 | 491 | 2022 |
| Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC) AC Tan Thoracic cancer 11 (3), 511-518, 2020 | 430 | 2020 |
| Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer JJ Lin, SV Liu, CE McCoach, VW Zhu, AC Tan, S Yoda, J Peterson, A Do, ... Annals of Oncology 31 (12), 1725-1733, 2020 | 197 | 2020 |
| Molecular pathways for cancer chemoprevention by dietary phytochemicals AC Tan, I Konczak, DMY Sze, I Ramzan Nutrition and cancer 63 (4), 495-505, 2011 | 169 | 2011 |
| FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma AC Tan, L Emmett, S Lo, V Liu, R Kapoor, MS Carlino, AD Guminski, ... Annals of Oncology 29 (10), 2115-2120, 2018 | 148 | 2018 |
| Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost … AC Tan, GGY Lai, G San Tan, SY Poon, B Doble, TH Lim, ZW Aung, ... Lung Cancer 139, 207-215, 2020 | 115 | 2020 |
| Removal torque comparison of TiUnite and turned implants in the greyhound dog mandible P Henry, A Tan, BP Allan, J Hall, C Johansson Appl Osseointegration Res 1, 15-17, 2000 | 80 | 2000 |
| Adapting to a pandemic—conducting oncology trials during the SARS-CoV-2 pandemic AC Tan, DM Ashley, M Khasraw Clinical Cancer Research 26 (13), 3100-3103, 2020 | 77 | 2020 |
| Systematic review of combinations of targeted or immunotherapy in advanced solid tumors AC Tan, SJ Bagley, PY Wen, M Lim, M Platten, H Colman, DM Ashley, ... Journal for immunotherapy of cancer 9 (7), 2021 | 70 | 2021 |
| Intratumoral CD39+ CD8+ T cells predict response to programmed cell death protein-1 or programmed death ligand-1 blockade in patients with NSCLC J Yeong, L Suteja, Y Simoni, KW Lau, AC Tan, HH Li, S Lim, JH Loh, ... Journal of Thoracic Oncology 16 (8), 1349-1358, 2021 | 66 | 2021 |
| Potential antioxidant, antiinflammatory, and proapoptotic anticancer activities of Kakadu plum and Illawarra plum polyphenolic fractions AC Tan, I Konczak, I Ramzan, D Zabaras, DMY Sze Nutrition and cancer 63 (7), 1074-1084, 2011 | 65 | 2011 |
| Native Australian fruit polyphenols inhibit cell viability and induce apoptosis in human cancer cell lines AC Tan, I Konczak, I Ramzan, DMY Sze Nutrition and cancer 63 (3), 444-455, 2011 | 58 | 2011 |
| Chemotherapy-induced peripheral neuropathy—patient-reported outcomes compared with NCI-CTCAE grade AC Tan, JM McCrary, SB Park, T Trinh, D Goldstein Supportive Care in Cancer 27, 4771-4777, 2019 | 54 | 2019 |
| The paradoxical effects of COVID-19 on cancer care: current context and potential lasting impacts A Broom, K Kenny, A Page, N Cort, ES Lipp, AC Tan, DM Ashley, ... Clinical Cancer Research 26 (22), 5809-5813, 2020 | 51 | 2020 |
| Antioxidant and cytoprotective activities of native Australian fruit polyphenols AC Tan, I Konczak, I Ramzan, DMY Sze Food Research International 44 (7), 2034-2040, 2011 | 50 | 2011 |
| Native Australian fruit polyphenols inhibit COX-2 and iNOS expression in LPS-activated murine macrophages AC Tan, DX Hou, I Konczak, S Tanigawa, I Ramzan, DMY Sze Food Research International 44 (7), 2362-2367, 2011 | 41 | 2011 |
| Immune checkpoint inhibitors in gliomas AC Tan, AB Heimberger, M Khasraw Current oncology reports 19, 1-11, 2017 | 39 | 2017 |
| Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer S Nanjo, W Wu, N Karachaliou, CM Blakely, J Suzuki, YT Chou, SM Ali, ... The Journal of clinical investigation 132 (13), 2022 | 38 | 2022 |
| Association of clinicopathologic and molecular tumor features with recurrence in resected early-stage epidermal growth factor receptor–positive non–small cell lung cancer SPL Saw, S Zhou, J Chen, G Lai, MK Ang, K Chua, R Kanesvaran, QS Ng, ... JAMA Network Open 4 (11), e2131892-e2131892, 2021 | 38 | 2021 |
